Jonathan Sheena - 20 Nov 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director, CO-FOUNDER
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
20 Nov 2025
Transactions value $
-$3,170,846
Form type
4
Filing time
21 Nov 2025, 20:05:07 UTC
Previous filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sheena Jonathan Director, CO-FOUNDER C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Vincent Fontanilla, Attorney-in-Fact 21 Nov 2025 0001646649

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$2.25M -10K -4.3% $225.08 223K 20 Nov 2025 Direct F1, F2
transaction NTRA Common Stock Sale -$460K -2K -7.91% $230.01 23.3K 21 Nov 2025 By Caraluna 1 Trust F3, F4, F5
transaction NTRA Common Stock Sale -$460K -2K -7.91% $230.01 23.3K 21 Nov 2025 By Caraluna 2 Trust F3, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.00 to $225.34 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.